0001144204-14-071672.txt : 20150130 0001144204-14-071672.hdr.sgml : 20150130 20141201191724 ACCESSION NUMBER: 0001144204-14-071672 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20141201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGI LABORATORIES, INC CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 6096971441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 CORRESP 1 filename1.htm

 

Mintz Levin only BW 2007

 

Avisheh Avini | 212 692 6200 | aavini@mintz.com

 

Chrysler Center

666 Third Avenue

New York, NY 10017

212-935-3000

212-983-3115 fax

www.mintz.com

 

December 1, 2014

 

Via EDGAR

 

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Mail Stop 3561
Washington, D.C. 20549

 

Re:IGI Laboratories, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2013
Filed March 31, 2014
File No. 001-08568

Attention of Johnny Gharib, Esq.

 

Ladies and Gentleman:

 

On behalf of IGI Laboratories, Inc. (the “Company”), and further to a telephone call with Johnny Gharib, Esq., we hereby request an extension to respond to the comments provided by a letter (the “Comment Letter”), dated November 12, 2014, from the staff at the Securities and Exchange Commission in relation to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, as originally filed with the Commission on March 31, 2014. The Company is working diligently on responses to the Comment Letter and intends to submit its response and the accompanying proposed revised disclosure by December 3, 2014.

 

If you have any questions or comments regarding the Company’s anticipated timing for the submission of its response, kindly contact me at (212) 692-6200. Thank you for your time and attention.

 

    Very truly yours,
     
    MINTZ, LEVIN, COHN, FERRIS, GLOVSKY & POPEO, P.C.
     
  By:   /s/ Avisheh Avini
    Avisheh Avini

 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

 

Boston| London | Los Angeles | New York |San Diego| San Francisco | Stamford | Washington

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/<]3U`:98279M;JZ"8S%:1>9(,;Z M\LM,-TMS9@&:.XA,;+R1C![@CFNJK-U[7+'PWHEUJ^I.R6ELH:0JN3R0!@=^ M2*SO"_C2P\7)YVFV6I+:E"R75Q:F.)\'&%8]3]/0UT=%%%%%%%%%<1XA^*6A M^%;O[/K-GJUKEV2.1[,^7+M/)1LX(Z?F*Z;1=876[(W26-]:)NP$O8#$[#`. M0IYQS6C111111111117S=:7DO@CXAQ^-GD8Z5JVL7]C>\?+&HF(!S^`;_@!K MZ0!#`$$$'D$=Z\<^-5Y-KECJ&A6DK):Z39_VCJ+J,YR3((O,\MB M-Q)[@]\8STS7L&@:]I_B71;;5M+G$UK.N5/=3W5AV(/!%<'/X>=?BU:Z:NL: MX-*DTR2]:V&IS;3*LJIUW9VX<<9QQ6GHOP_F1;R\U76=72^OKJ6YE@LM2EB@ MBW.2%4*1G`P"3U-UTJ[6*U5=4F4JI:0')#9/W1UK M;U7P#K46HZC)I&KWUS#>Z4]E'_:-\\OV:221`SIGG_5ACZY7&>:W+3P%:65D MD4GB#Q)+Y:_-+)K$PSCJ3A@!7`^$[>_\:>/KJ\TO7=<3P?I<@C!DU&5_MTR\ M\$M]WD9]L?WN/;*\7_:&`.F^&@1G_B8'^0KVBL+QC8+?>%M0/VF\MI(())HI M;2Y>%U=4.#E2,CV.17"?"W2IO%7@&RU;5=>\027DLDJNR:K,@PKD#@-CH!6S M'X#U(-KED?$>M&SF6.;3;EM2D,UO+APZD@_,N=AP<]3W&:S/@GJ-Q?:1JUOJ MUW?3Z[8WC6]X+JZ>7`R=I"L2%YW#@<[:W/B>\H\,PV]C/=PZO>74=KIYMKEX M3YSGJVTC*JH9CG(XHU?PHFG>`KZ(:QK3WEM:23B].HS"1I5C/S?>QC(^[T]J MQ?A)8/K_`,.X=4U75-7NKR_,J2R/J,PVA9"!LPPVGY1R.>O.#BN6TOQ9K/@# MQWJ::Q>ZAJ'A%]0.GBZNYFF:UD"JZY)YQM<9]0">2N*]PGA@U/3VC\US!.@Q M);S%"5/(*NI!'U!K@?`.CS1^)_$C7>L:O>)INH&VM(KF_E=$C,8;E2<,?GQE ML]*]'HKR32/#4?CCX(W=EA3<75U>7-LY_AF%Q(5.??&#[$T[X8?$.'_A6%Y) MK4A6[\.H8;E6X=D`_=]>YQL]ROO1K>C7.G?!/Q)?ZFN-9U:(WM]_L,Q7;&/9 M%VKCV/K73?"5P_PL\/D?\^Y'Y.PKF?A)_P`CO\1_^PM_[/-73.JO\90C@,K> M'6!4C.1]H&:XG4[.[^"_B9M;TN*2?P9J,H%]:)S]CD/`91Z>G_?)_A-=A;W] MKJGQ5TJ^L9TGM9_#T[Q2H*I_AI8R:5KVGVEL9)O+AFTTRL#YC9RXD7/.3TKT+X?V>H6'@NRMM51UOTD MG,^_JS&9R6'L1-V5;@8`/XG9_WVU=9; M+_PD7Q)N+T_-8^'8C:P^C7U?J[5N>*?^11UK_KPG_\`1;5R'P-_ MY)+I/^_/_P"CGJ?0=&L/$"^.]+U*!9[2XUIT=#_UPAP0>Q!Y![&N9\,:S?\` MPK\21^#/$UPTN@W+$Z1JQK$N?AC._QN;48DE7P_=1B_NT7(CDG1AB-NQRX63!] MZZGXI3W5QX/U#1+'1]1U"[OX"D9MH-T:'(Y9LX'K6;\,M1OM"\!VNCZMX?UJ MWN].B,O%$^H^'-8MK;7;X3VLKVV0 M@WN?WF#\O#C]:U+C5[^/XKKK(\.:V^EQZ6U@TRV1),GFA\AO1;NT MMM2L9K2\@2:VG0I)%(N0RD<@BO+/!/@&_P#!'Q1N(XGN+CP_)I\WV&1B6%N6 MDC9HSZ'C/^UC/7->HZA>C3[*2Z:"XG"8_=V\1D=LG'"CDUY-\/GU72?'WBF_ MU#PWK-O::[=K):RM:D[!O?\`UF#\O#@^V#7H_BS5[_1/#\]UI>EW&IWY^2WM MX4+9<]"WHHZG\N]>;?#>.[\+V]]J>N>'/$-UXCU.9I+RX6S#`#/"J=W3N>G4 M#L*Z7Q!XVUR739;3P_X1U[^TKA?+AGN;54BA9N-['<>F9].NGDDG>WVQMC@;"3\P/)S7

@/O57X8:EJWA#P5#HNK^$M>$]O)(P>"V$BLK,6_O9SR M>,5U-CXAUOQ!XNL8+;1M4TO1K:.2:[FO[<1FX;&U(U&20`6W$]3M_.#XN^&I M?$G@.Y%G$[ZC8NMW:"-27++U`QR25)X]<5N^#-%DT'PK9VERYDOG!N+R5N6D MGD.^1B>_S$_@!4?C6]EMO#%];V^G7U]<7=O+!%':0F3YF0@;CT49/4UROPEE MOO#_`(#CT;5=#U:VN[!997W6I*R@N6`0C[S?-TZ\&I?`>HW]OK_B"*^T#6+2 M+5-3>[M99;8[-A15^<@_(?D'7UKJ_%OA33?&6@3Z1J<>8W^:.51\T+CHZ^X_ M49'>N5^$?AW6O#-EKMAKC22W"Z@-EPY)$\8B0*RD]1@`>V,=J]&HHHHHHHHH 1HHHHHHHHHHHHHHHHHHHK_]D_ ` end